Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Novira Therapeutics patents

Patents where

Current Assignee

Name

Novira Therapeutics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10987359 Oxadiazepinone derivatives and methods of treating hepatitis B infections	Patent 10987359 was granted and assigned to Novira Therapeutics on April, 2021 by the United States Patent and Trademark Office.	Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	10987359	April 27, 2021
‌ US Patent 10975077 Diazepinone derivatives and their use in the treatment of hepatitis B infections	Patent 10975077 was granted and assigned to Novira Therapeutics on April, 2021 by the United States Patent and Trademark Office.	Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	10975077	April 13, 2021
‌ US Patent 9597332 Sulfide alkyl compounds for HBV treatment	Patent 9597332 was granted and assigned to Novira Therapeutics on March, 2017 by the United States Patent and Trademark Office.	Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	9597332	March 21, 2017
‌ US Patent 10196351 Sulfide alkyl compounds for HBV treatment	Patent 10196351 was granted and assigned to Novira Therapeutics on February, 2019 by the United States Patent and Trademark Office.	Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	10196351	February 5, 2019
‌ US Patent 10428041 Pyridyl reverse sulfonamides for HBV treatment	Patent 10428041 was granted and assigned to Novira Therapeutics on October, 2019 by the United States Patent and Trademark Office.	Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	10428041	October 1, 2019
‌ US Patent 10160742 Pyridyl reverse sulfonamides for HBV treatment	Patent 10160742 was granted and assigned to Novira Therapeutics on December, 2018 by the United States Patent and Trademark Office.	Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	10160742	December 25, 2018
‌ US Patent 9765050 Pyridyl reverse sulfonamides for HBV treatment	Patent 9765050 was granted and assigned to Novira Therapeutics on September, 2017 by the United States Patent and Trademark Office.	Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	9765050	September 19, 2017
‌ US Patent 10544141 Derivatives and methods of treating hepatitis B infections	Patent 10544141 was granted and assigned to Novira Therapeutics on January, 2020 by the United States Patent and Trademark Office.	Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	10544141	January 28, 2020
‌ US Patent 10077264 Derivatives and methods of treating hepatitis B infections	Patent 10077264 was granted and assigned to Novira Therapeutics on September, 2018 by the United States Patent and Trademark Office.	Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	10077264	September 18, 2018
‌ US Patent 10093669 Derivatives and methods of treating hepatitis B infections	Patent 10093669 was granted and assigned to Novira Therapeutics on October, 2018 by the United States Patent and Trademark Office.	Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	10093669	October 9, 2018
‌ US Patent 9181288 Azepane derivatives and methods of treating hepatitis B infections	Patent 9181288 was granted and assigned to Novira Therapeutics on November, 2015 by the United States Patent and Trademark Office.	Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	9181288	November 10, 2015
‌ US Patent 9527845 Derivatives and methods of treating hepatitis B infections	Patent 9527845 was granted and assigned to Novira Therapeutics on December, 2016 by the United States Patent and Trademark Office.	Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	9527845	December 27, 2016
‌ US Patent 10538519 Derivatives and methods of treating hepatitis B infections	Patent 10538519 was granted and assigned to Novira Therapeutics on January, 2020 by the United States Patent and Trademark Office.	Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	10538519	January 21, 2020
‌ US Patent 10632112 Combination therapy for treatment of HBV infections		Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	10632112	April 28, 2020
‌ US Patent 10189835 Derivatives and methods of treating hepatitis B infections	Patent 10189835 was granted and assigned to Novira Therapeutics on January, 2019 by the United States Patent and Trademark Office.	Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	10189835	January 29, 2019
‌ US Patent 9676747 Hepatitis B antiviral agents	Patent 9676747 was granted and assigned to Novira Therapeutics on June, 2017 by the United States Patent and Trademark Office.	Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	9676747	June 13, 2017
‌ US Patent 9518057 Derivatives and methods of treating hepatitis B infections	Patent 9518057 was granted and assigned to Novira Therapeutics on December, 2016 by the United States Patent and Trademark Office.	Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	9518057	December 13, 2016
‌ US Patent 9339510 Azepane derivatives and methods of treating hepatitis B infections	Patent 9339510 was granted and assigned to Novira Therapeutics on May, 2016 by the United States Patent and Trademark Office.	Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	9339510	May 17, 2016
‌ US Patent 9066932 Hepatitis B antiviral agents	Patent 9066932 was granted and assigned to Novira Therapeutics on June, 2015 by the United States Patent and Trademark Office.	Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	9066932	June 30, 2015
‌ US Patent 9873671 Azepane derivatives and methods of treating hepatitis B infections	Patent 9873671 was granted and assigned to Novira Therapeutics on January, 2018 by the United States Patent and Trademark Office.	Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	9873671	January 23, 2018
‌ US Patent 8993771 Hepatitis B antiviral agents	Patent 8993771 was granted and assigned to Novira Therapeutics on March, 2015 by the United States Patent and Trademark Office.	Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	8993771	March 31, 2015
‌ US Patent 9884831 Azocane and azonane derivatives and methods of treating hepatitis B infections	Patent 9884831 was granted and assigned to Novira Therapeutics on February, 2018 by the United States Patent and Trademark Office.	Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	9884831	February 6, 2018
‌ US Patent 9550779 Derivatives and methods of treating hepatitis B infections	Patent 9550779 was granted and assigned to Novira Therapeutics on January, 2017 by the United States Patent and Trademark Office.	Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	9550779	January 24, 2017
‌ US Patent 9400280 Piperidine derivatives and methods of treating hepatitis B infections	Patent 9400280 was granted and assigned to Novira Therapeutics on July, 2016 by the United States Patent and Trademark Office.	Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	9400280	July 26, 2016
‌ US Patent 10710959 Sulfide alkyl compounds for HBV treatment		Novira Therapeutics	Novira Therapeutics	United States Patent and Trademark Office	10710959	July 14, 2020

Results per page:

42 results

0 selected

42 results

0 selected